• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4617544)   Today's Articles (177)   Subscriber (49400)
For: Das P, Oliphant CS, Beach E, Thapa R. Emerging antiplatelet agents, differential pharmacology, and clinical utility. J Blood Med 2010;1:79-91. [PMID: 22282687 PMCID: PMC3262324 DOI: 10.2147/jbm.s6596] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2010] [Indexed: 11/24/2022]  Open
Number Cited by Other Article(s)
1
Danielak D, Karaźniewicz-Łada M, Główka F. Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy. Expert Opin Pharmacother 2017;19:103-112. [DOI: 10.1080/14656566.2017.1421634] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
2
Chandasana H, Chhonker YS, Prasad YD, Laxman TS, Anil Kumar KS, Dikshit DK, Bhatta RS. Pharmacokinetics and tissue distribution study of novel potent antiplatelet agent S007-867 in mice using HPLC-MS/MS. Xenobiotica 2015;45:530-7. [DOI: 10.3109/00498254.2014.994053] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
3
Juneja S, Gupta K, Kaushal S. Ticagrelor: An emerging oral antiplatelet agent. J Pharmacol Pharmacother 2013;4:78-80. [PMID: 23662033 PMCID: PMC3643352 DOI: 10.4103/0976-500x.107698] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA